查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1825612

2025年全球人工胰臟装置系统市场报告

Artificial Pancreas Device System Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年人工胰臟装置系统市场将快速成长，到2029年将达到34.6亿美元，年复合成长率（CAGR）为13.8%。预测期内的成长可归因于糖尿病盛行率的上升、胰臟癌盛行率的上升、糖尿病和肥胖症发病率的上升、对微创 (MI) 给药系统的需求不断增长以及糖尿病管理技术的创新驱动。预测期内的主要趋势包括技术创新、研发活动增加、产品核可增加、合作伙伴关係和协作增加以及远端咨询活动的增加。

未来五年13.8%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。关税上涨可能会增加来自瑞士和法国的闭合迴路胰岛素输送系统和血糖预测演算法的成本，加剧第1型糖尿病患者的治疗成本，进而对美国的糖尿病管理造成压力。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，关税上涨的影响也可能更加广泛。

胰臟癌发病率的上升预计将推动人工胰臟装置系统 (APDS) 市场的扩张。胰臟癌是一种发生于胰臟（位于胃后方）的恶性肿瘤。胰臟癌的发展受到生活方式、遗传、医疗和环境因素等多种因素的影响，包括导致遗传性胰臟炎和慢性胰臟炎的基因突变。人工胰臟装置系统主要用于透过自动监测血糖和输送适量的胰岛素来帮助糖尿病患者管理血糖值。例如，根据澳洲政府机构 TheCancer Australia 在 2024 年 3 月的数据，估计 2023 年新诊断的胰臟癌病例为 4,506 例，高于前五年的 3,751 例。因此，胰臟癌发生率的上升正在促进人工胰臟装置系统市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工胰臟设备系统：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球人工胰臟装置系统市场：成长率分析
  • 全球人工胰臟装置系统市场表现：规模与成长，2019-2024
  • 全球人工胰臟装置系统市场预测：规模与成长，2024-2029年，2034年
  • 全球人工胰臟设备系统：总目标市场（TAM）

第六章 市场细分

  • 全球人工胰臟装置系统市场：按设备类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 阈值暂停设备系统
  • 控制距离系统
  • 控制目标体系
  • 全球人工胰臟装置系统市场：依治疗类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 双激素
  • 仅胰岛素
  • 杂交种
  • 全球人工胰臟装置系统市场：依最终用户、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 医疗中心
  • 其他最终用户
  • 全球人工胰臟装置系统市场：细分阈阈值悬浮装置系统（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 具有阈值停止功能的胰岛素泵
  • 持续血糖监测（CGM）整合系统
  • 全球人工胰臟装置系统市场：依控制距离系统细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 混合封闭回路型系统
  • 控程胰岛素输送系统
  • 即时血糖控制系统
  • 全球人工胰臟装置系统市场：依控制目标系统细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 完全封闭回路型人工胰臟系统
  • 具有目标血糖控制功能的胰岛素泵
  • 自动血糖控制系统

第七章 区域和国家分析

  • 全球人工胰臟装置系统市场：区域分析、预测（2019-2024 年、2024-2029 年、2034 年）
  • 全球人工胰臟装置系统市场：依国家/地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 人工胰臟装置系统市场：竞争格局
  • 人工胰臟设备系统市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Tandem Diabetes Care Inc.
  • Juvenile Diabetes Research Foundation（JDRF）
  • Beta Bionics Inc.
  • Glooko Inc.
  • Bigfoot Biomedical Inc.
  • CeQur SA
  • Medtrum Technologies Inc.
  • Diabeloop SA
  • Beta-O2 Technologies Ltd
  • Pancreum Inc.
  • TypeZero Technologies LLC
  • Inreda Diabetic BV
  • Defymed SAS
  • Admetsys Corporation
  • DreaMed Diabetes Ltd

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年人工胰臟装置系统市场：提供新机会的国家
  • 2029年人工胰臟设备系统市场：细分市场带来新机会
  • 2029年人工胰臟装置系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29437u

An Artificial Pancreas Device System (APDS) is a medical technology designed to automate blood glucose management for people with diabetes. This system combines continuous glucose monitoring (CGM) with an insulin pump and employs a sophisticated algorithm to adjust insulin delivery automatically based on real-time glucose readings. The goal of the device is to replicate the glucose-regulating function of a healthy pancreas, thus minimizing the need for manual blood glucose monitoring and insulin injections, and assisting in keeping blood glucose levels within a target range.

The artificial pancreas device system market features three main types of devices threshold suspend device systems, control-to-range systems, and control-to-target systems. Threshold suspend device systems are insulin pump technologies that automatically halt insulin delivery when blood glucose levels fall below a set threshold. The different treatment types include bi-hormonal, insulin-only, and hybrid systems, with end-users such as hospitals, medical centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The artificial pancreas device system market research report is one of a series of new reports from The Business Research Company that provides artificial pancreas device system market statistics, including the artificial pancreas device system industry global market size, regional shares, competitors with artificial pancreas device system market share, detailed artificial pancreas device system market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial pancreas device system industry. These artificial pancreas device system market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial pancreas device system market size has grown rapidly in recent years. It will grow from $1.81 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to rising inflow of investment, growing government initiative in clinical research, growing demand for automated systems in glycemic control, intensive R&D efforts by industry players, and increasing geriatric population.

The artificial pancreas device system market size is expected to see rapid growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to growing prevalence of diabetes, increasing prevalence of pancreatic cancer, growing occurrence of diabetes and obesity, rising demand minimally invasive (MI) drug delivery systems, and driving innovation in diabetes management technology. Major trends in the forecast period include technological innovations, increasing research and development activities, increasing product approvals, partnerships and collaborations, and increasing activities in tele consultancy for follow-up.

The forecast of 13.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. diabetes management by driving up the cost of closed-loop insulin delivery systems and glucose prediction algorithms sourced from Switzerland and France, exacerbating treatment costs for Type 1 diabetes patients. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of pancreatic cancer is projected to drive the expansion of the artificial pancreas device system (APDS) market. Pancreatic cancer is a malignant tumor originating in the pancreas, which is located behind the stomach. The development of pancreatic cancer is influenced by a mix of lifestyle, genetic, medical, and environmental factors, including genetic mutations that can cause hereditary pancreatitis and result in chronic pancreatic inflammation. An artificial pancreas device system is primarily designed to assist individuals with diabetes in managing their blood sugar levels by automatically monitoring glucose and delivering the appropriate amount of insulin. For example, in March 2024, according to theCancer Australia, an Australia-based government agency, estimated that 4,506 new cases of pancreatic cancer were diagnosed in 2023, up from 3,751 cases over the previous five years. Thus, the rising prevalence of pancreatic cancer is contributing to the growth of the artificial pancreas device system market.

Key players in the artificial pancreas device system market are developing automated insulin delivery systems to improve diabetes management by automatically monitoring blood glucose levels and administering the correct amount of insulin. These systems aim to mimic the function of a healthy pancreas, alleviating the need for constant blood sugar monitoring and manual insulin injections. For instance, in May 2023, Beta Bionics, a US-based medical equipment manufacturer, received FDA 510(k) clearance for its iLet Insulin-Only Bionic Pancreas System, an automated insulin delivery device. This artificial pancreas system autonomously determines and delivers insulin doses to regulate blood glucose levels. The closed-loop system adjusts insulin delivery based on glucose levels measured by a connected continuous glucose monitor (CGM), requiring only the user's body weight and a meal size estimate for automatic adjustments.

In September 2023, Abbott Laboratories, a US-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed amount. This acquisition strengthens Abbott's position in diabetes care by integrating its leading Freestyle Libre continuous glucose monitoring technology with Bigfoot Biomedical's expertise in automated insulin delivery systems. Bigfoot Biomedical, a US-based company, specializes in developing prototypes of automated insulin delivery systems, also known as artificial pancreas systems.

Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd

North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial pancreas device system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial pancreas device system market includes revenues earned by entities by providing services such as patient monitoring, device maintenance, data management, software updates, healthcare provider consultations, and training and support for patients and healthcare professionals. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial pancreas device system market also includes sales of insulin pumps, continuous glucose monitors, control algorithms and software applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Pancreas Device System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial pancreas device system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial pancreas device system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial pancreas device system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
  • 2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
  • 3) By End-User: Hospitals; Medical Centers; Other End-Users
  • Subsegments:
  • 1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
  • 2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
  • 3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; DexCom Inc.; Insulet Corporation; Tandem Diabetes Care Inc.; Juvenile Diabetes Research Foundation (JDRF); Beta Bionics Inc.; Glooko Inc.; Bigfoot Biomedical Inc.; CeQur SA; Medtrum Technologies Inc.; Diabeloop SA; Beta-O2 Technologies Ltd; Pancreum Inc.; TypeZero Technologies LLC; Inreda Diabetic B.V.; Defymed SAS; Admetsys Corporation; DreaMed Diabetes Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Pancreas Device System Market Characteristics

3. Artificial Pancreas Device System Market Trends And Strategies

4. Artificial Pancreas Device System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Pancreas Device System Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Pancreas Device System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Pancreas Device System Market Growth Rate Analysis
  • 5.4. Global Artificial Pancreas Device System Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Pancreas Device System Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Pancreas Device System Total Addressable Market (TAM)

6. Artificial Pancreas Device System Market Segmentation

  • 6.1. Global Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Threshold Suspend Device Systems
  • Control-To-Range Systems
  • Control-To-Target Systems
  • 6.2. Global Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bi-Hormonal
  • Insulin Only
  • Hybrid
  • 6.3. Global Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Medical Centers
  • Other End-Users
  • 6.4. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Threshold Suspend Device Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pump with Threshold Suspend
  • Continuous Glucose Monitoring (CGM) Integrated Systems
  • 6.5. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Range Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybrid Closed-Loop Systems
  • Insulin Delivery Systems with Range Control
  • Real-Time Glucose Adjustment Systems
  • 6.6. Global Artificial Pancreas Device System Market, Sub-Segmentation Of Control-To-Target Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fully Closed-Loop Artificial Pancreas Systems
  • Insulin Pumps with Targeted Glucose Control
  • Automated Glucose Regulation Systems

7. Artificial Pancreas Device System Market Regional And Country Analysis

  • 7.1. Global Artificial Pancreas Device System Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Pancreas Device System Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Pancreas Device System Market

  • 8.1. Asia-Pacific Artificial Pancreas Device System Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Pancreas Device System Market

  • 9.1. China Artificial Pancreas Device System Market Overview
  • 9.2. China Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Pancreas Device System Market

  • 10.1. India Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Pancreas Device System Market

  • 11.1. Japan Artificial Pancreas Device System Market Overview
  • 11.2. Japan Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Pancreas Device System Market

  • 12.1. Australia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Pancreas Device System Market

  • 13.1. Indonesia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Pancreas Device System Market

  • 14.1. South Korea Artificial Pancreas Device System Market Overview
  • 14.2. South Korea Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Pancreas Device System Market

  • 15.1. Western Europe Artificial Pancreas Device System Market Overview
  • 15.2. Western Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Pancreas Device System Market

  • 16.1. UK Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Pancreas Device System Market

  • 17.1. Germany Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Pancreas Device System Market

  • 18.1. France Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Pancreas Device System Market

  • 19.1. Italy Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Pancreas Device System Market

  • 20.1. Spain Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Pancreas Device System Market

  • 21.1. Eastern Europe Artificial Pancreas Device System Market Overview
  • 21.2. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Pancreas Device System Market

  • 22.1. Russia Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Pancreas Device System Market

  • 23.1. North America Artificial Pancreas Device System Market Overview
  • 23.2. North America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Pancreas Device System Market

  • 24.1. USA Artificial Pancreas Device System Market Overview
  • 24.2. USA Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Pancreas Device System Market

  • 25.1. Canada Artificial Pancreas Device System Market Overview
  • 25.2. Canada Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Pancreas Device System Market

  • 26.1. South America Artificial Pancreas Device System Market Overview
  • 26.2. South America Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Pancreas Device System Market

  • 27.1. Brazil Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Pancreas Device System Market

  • 28.1. Middle East Artificial Pancreas Device System Market Overview
  • 28.2. Middle East Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Pancreas Device System Market

  • 29.1. Africa Artificial Pancreas Device System Market Overview
  • 29.2. Africa Artificial Pancreas Device System Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Pancreas Device System Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Pancreas Device System Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Pancreas Device System Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Pancreas Device System Market Competitive Landscape
  • 30.2. Artificial Pancreas Device System Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. DexCom Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Pancreas Device System Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Juvenile Diabetes Research Foundation (JDRF)
  • 31.3. Beta Bionics Inc.
  • 31.4. Glooko Inc.
  • 31.5. Bigfoot Biomedical Inc.
  • 31.6. CeQur SA
  • 31.7. Medtrum Technologies Inc.
  • 31.8. Diabeloop SA
  • 31.9. Beta-O2 Technologies Ltd
  • 31.10. Pancreum Inc.
  • 31.11. TypeZero Technologies LLC
  • 31.12. Inreda Diabetic B.V.
  • 31.13. Defymed SAS
  • 31.14. Admetsys Corporation
  • 31.15. DreaMed Diabetes Ltd

32. Global Artificial Pancreas Device System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Pancreas Device System Market

34. Recent Developments In The Artificial Pancreas Device System Market

35. Artificial Pancreas Device System Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Pancreas Device System Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Pancreas Device System Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Pancreas Device System Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer